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Summary 
Mice transgenic for SV40 T antigen (Tag) under control 
of the rat insulin promoter (RIP) develop two altema- 
tive immunological phenotypes: tolerance or autoim- 
munity towards Tag. We utlllzed the T cell receptor 
(TCR) genes expressed in a Tag-specific CD4+ cell 
from an autoimmune RIP-Tag mouse to generate two 
lines of TCR transgenic mice in which either 10% or 
90% of peripheral T cells express the transgenic TCR. 
When cross-bred to the tolerant RIPl-Tag2 line, mice 
from the low frequency TCR line showed partlal dela 
tlon of peripheral Tag-specific T cells and nonrespon- 
siveness of those that remained. In contrast, cross- 
bred mice in which transgenlc T cells comprlaed a 
majority of the T cell population were nontolerant both 
in vivo and in vitro. Thus, tolerkation of CD4+ T cells 
specific for a mre self-antigen may fail if too many auto- 
reactive T cells develop. 
Introduction 
During development of the immune system, T and B lym- 
phocytes with specificity for the self-antigens of the body 
must be either inactivated or eliminated from the functional 
lymphocyte pool. Studies on the mechanism of this pro- 
cess of tolerance induction, especially in the T cell com- 
partment, have long been hampered by the inability to 
monitor antigen-specific T cells in the intact organism, ow- 
ing to their low frequency and the lack of specific markers. 
This limitation has, to some extent, been overcome 
through the analysis of abundant classes of T cells that 
bind superantigens (reviewed by Blackman et al., 1990), 
and by the use of T cell receptor (TM) transgenic mice, 
in which rearranged TCR a and 5 genes introduced into 
the mouse germline instruct a majority of developing T 
cells to express the transgenic antigen receptor (for review 
see von Boehmer, 1990). Pioneering studies using such 
TCR transgenic mice have demonstrated that potentially 
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autoreactive T cells specific for antigens abundantly ex- 
pressed in the thymus are deleted during their develop- 
ment, predominantly at the CD4+CD8’ stage (Kisielow et 
al., 1988; Sha et al., 1988a; Berg et al., 1989a; Vasquez 
et al., 1992). 
The situation is less clear, however, if the target antigen 
is expressed in a tissue-specific fashion, or only at limiting 
amounts in the thymus. For example, several reports have 
described potentially self-reactive CD8+ T cells against 
antigens expressed in the pancreatic 8 cells. In two cases, 
rather than becoming tolerized by their target antigen, the 
transgenic T cells instead ignored it in the 8 cells, while 
remaining fully reactive toward exogenously introduced 
antigen (Ohashi et al., 1991; Heath et al., 1992). In another 
study where the target antigen (simian virus 40 T antigen 
[SV40 Tag]) was expressed at a relatively late timepoint 
in ontogeny in either the pancreatic 8 cells or the exocrine 
pancreas, the T antigen-specific CD8+ transgenic T cells 
invaded the pancreas and caused a severe autoimmune 
reaction (Geiger et al., 1992, 1993). In contrast, H&m- 
merling and colleagues described distinct stages of nonre- 
sponsiveness in CD8+ transgenic T cells using Kb-specific 
TCR transgenic mice crossed to either keratin IV, glial 
fibrillary acidic protein (GFAP), or albumin-promoted Kb 
transgenic mice (reviewed by HBmmerling et al., 1993), 
implying that tolerance by CD8+ T cells can be established 
toward tissue-specific antigens. 
Remarkably, only very few TCR transgenic mouse mod- 
els have been described in which CD4+ T cells specific 
for processed peptide antigens are efficiently tolerized. 
In these models, the target antigen was either present 
abundantly in the circulation as a self-protein (Zal et al., 
1994), or the antigen was administered in large amounts 
as an exogenous protein or peptide (Murphy et al., 1990; 
Critchfield et al., 1994; Kearney et al., 1994). Three other 
studies have described transgenic mice expressing re- 
arranged TCR genes originating from autoreactive CD4+ 
T cell clones, specific for either myelin basic protein (Gov- 
erman et al., 1993; Lafaille et al., 1994) or an unknown 
antigen expressed in 5 islet cells of NOD mice (Katz et 
al., 1993). In all of the latter cases, the transgenic CD4+ 
T cells did not become tolerant towards the respective 
self-antigen, but rather developed spontaneous autoim- 
mune reactions. One might argue that, in these particular 
genetic backgrounds, the mice are prone to develop auto- 
immunity and therefore tolerance induction was bound to 
fail. This consideration does not hold true for the system 
described by Scott et al. (1994), in which TCR transgenic 
mice with CD4+ transgenic T cells specific for influenza 
hemagglutinin (HA) were bred to rat insulin promoter-influ- 
enza hemagglutinin (RIP-HA) transgenic mice. Although 
the RIP-HA mice were previously shown to be tolerant in 
the CD4+ T cell compartment (Lo et al., 1992), the 
transgenic anti-HA CD4+T cells were clearly not tolerant in 
vitro, and, depending on genetic background, developed 
profound autoimmunity in vivo (Scott et al., 1994). One 
may conclude from these findings that tolerization of CD4+ 
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T cells in TCR transgenic mice is difficult to achieve and 
does not necessarily follow the same rules as in the un- 
manipulated immune system. 
In the present study, we analyze the induction of T cell 
tolerance versus autoimmunity in transgenic mice ex- 
pressing the simian virus 40 large Tag under control of 
the rat insulin II gene promoter (RIP-Tag mice, Hanahan, 
1985). These mice have been shown to develop either 
immunologic nonresponsiveness or spontaneous autoim- 
munity, depending on the temporal onset of expression 
of the Tag transgene (Adams et al., 1987). Helper and 
cytotoxic T cells of RIP1 -Tag2 (RT2) mice with early onset 
of Tag expresssion (starting at embryonic day 10) were 
shown to be tolerant towards Tag (Jolicoeur et al., 1994). 
In contrast, RIP1 -Tag3 and RIPl-Tag5 mice express Tag 
starting from 8-l 0 weeks of age and subsequently develop 
an autoimmune response, characterized by spontaneous 
production of Tag-specific autoantibodies and lympho- 
cytic infiltration of the pancreatic islets (Adamset al., 1987; 
Skowronski et al., 1990; unpublished data). The lympho- 
cytic infiltration of pancreatic islets in RIP-Tag mice with 
delayed onset of Tag expression provided us with a source 
from which to isolate Tag-specific CD4+ T cell lines that 
were involved in the autoimmune response. We have used 
the genes encoding one of these autoreactive TCRs to 
generate TCR transgenic mice. These mice were then 
crossed to the tolerant RT2 line, to ask whether in this 
background the potentially autoreactive cells recognizing 
the neo self-antigen Tag could be rendered tolerant. The 
experimental design is shown in Figure 1. 
We report here that tolerance of the CD4+ Tag-specific T 
cells can be achieved in Tag-TCRIRT2 dou ble-transgenic 
mice. However, the development of tolerance in these 
mice is critically dependent on the frequency of the 
Figure 1. Schematic Outline of the Experimental Strategy and the 
Transgenic Mice Used in this Study 
Pancreatic islets were isolated from an autoimmune RIPI-Tag5 
mouse, and T cell lines derived. The TCR genes from a Tag-specific 
CD4+ T cell were cloned and used to derive two lines of Tag-TCR 
transgenic mice, which were cross-bred to tolerant RT2 mice to assess 
the effects of Tag expression on development of Tag-specific T cells. 
Additionally, an anti-idiotypic monoclonal antibody speciflcforthis anti- 
Tag TCR was produced, to allow visualization of the transgenic T cells 
(Id+). 
transgenic T cells and fails if the number of autoreactive 
T cells is too high. 
Results 
Isolation of TagSpecIfIc T Cell Lines and Cloning 
of TCR Genes 
Tag-specific T cell lines were isolated directly from infil- 
trated islets from the pancreas of a 28-week-old autoim- 
mune RIPl-Tag5 mouse. In brief, individual islets were 
cultured in the presence of interleukin-2 (IL-2), and the 
outgrowing lymphocytes were expanded by several 
rounds of restimulation with purified Tag protein. Two 
CD4+ T cell lines were established in long-term culture, 
and their antigen specificity was confirmed by Tag 
dependent secretion of IL-2or 114, and interferonT(IFN+r). 
Because of its strong reactivity to Tag, the CD4+ cell line 
2.5T was chosen for cDNA cloning of the expressed TCR 
gene rearrangements. This cell line was found to be com- 
posed of at least two different T cell clones. Therefore, 
we generated several T cell hybridomas from 2.5T cells 
to obtain monoclonal cell lines for confirmation of antigen 
specificity and genomic cloning of the TCR gene rearrange 
merits. Hybridoma 2.5T.3.43 was shown to express a 
V88.3.DP2.1 J82.4 and aVcd?JaMTl-27 rearrangement and 
to respond specifically to Tag stimulation by secretion of 
IL-2 in the presence of irradiated C3H spleen cells (data 
not shown). 
To construct the Tag-specific TCR genes for production 
of transgenic mice, the rearranged genomic variable gene 
segments of the TCR a and 8 chains were cloned from 
size-selected genomic libraries of hybridoma 2.5T.3.43, 
and inserted into cosmid vectors already containing the 
TCR a and 8 constant region genes (see Experimental 
Procedures). These cosmid vectors (provided by D. Loh 
and K. Murphy) had previously been shown to be efficiently 
expressed in TCR transgenic mice (Sha et al., 1988b; Mur- 
phy et al., 1990). 
Generatlon of TCR Tranagenic Mice 
The reconstructed TCR a and 8 chain genes encoding 
the Tag-specific TCR were coinjected into fertilized eggs 
of B8D2F2 mice. Two independent TCR afl double- 
transgenic mice, designated Tag-TCRl and Tag-TCR2, 
were obtained and backcrossed to C3HeBIFe to establish 
lines (see also Experimental Procedures). To facilitate de- 
tection and monitoring of T cells expressing the Tag- 
specificTCR in the transgenic mice, we generated an anti- 
idiotypic monoclonal antibody (designated 9H5) that 
exclusively recognizes the 2.5T.3.43 TCR encoded by the 
transgenic a and 8 chain genes (see Experimental Proce- 
dures). 
Expression ProflIes of Tag-Specific T Cells 
in Thymus and Periphery 
Surprisingly, expression of the transgenic TCR was quite 
different in the two independent transgenic lines. While 
almost all thymocytes of Tag-TCR2 mice were idiotype 
positive (Id+) and thus carry the Tag-specific TCR on their 
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cell surface, only 0.5%-l .O% of total thymocytes and ap- 
proximately 5% of the CD3hi thymocytes were Id+ in Tag- 
TCRl mice (Figure 2). Correspondingly, Tag-specific (Id+) 
T cells accounted for more than 90% of peripheral T cells 
in Tag-TCR2 mice, but only for about 10% of peripheral 
T cells in Tag-TCRl mice. The low frequency of Tag- 
specific T cells in Tag-TCRl mice could result from the 
lack of allelic exclusion of the endogenous versus 
transgenic TCR a genes as previously reported (Borgulya 
et al., 1992; Malissen et al., 1992; Padovan et al., 1993), 
or from heterogeneous expression of the transgene locus. 
To address these possibilities, we analyzed the Tag-TCRI 
mice for expression of the transgenic 8 chain by staining 
with the Vf38.3-specific monoclonal antibody 7G8 (see 
Experimental Procedures). The frequency of V88.3+ T 
cells in lymph nodes of Tag-TCRl mice was 30% of all 
T cells, which is 3-fold higher than the frequency of V88.3+ 
T cells in normal C3H mice, but lower than the 800/b-90% 
levels typically seen in Vp TCR transgenic mice (data not 
shown). Thus, two-thirds of the V88.3’ T cells must ex- 
press a rearranged endogenous Vu gene and the other 
one-third the transgenic Vu, while the remaining 70% of 
all T cells that are not V88.3+ apparently express an endog- 
enous Vp. Therefore, both transgenic TCR chains are ex- 
pressed in only a subset of T cells. Given previous data 
suggesting that allelic exclusion of TCR 8 chains is very 
effective, we presume that the low frequencies of I/88.3+ 
and of Tag-specific (Id+) T cells in Tag-TCRl mice are 
due tovariable expression of the transgenes resulting from 
influences of the integration site. Despite the lower fre- 
quency of Id+ T cells in Tag-TCRl mice, the level of Id 
expression per cell, i.e., the amount of Tag-specific TCR 
on the surface of Id+ cells, was not significantly different 
from that of Tag-TCR2 mice (see Figure 2). 
The overall number of thymocytes was normal in Tag- 
TCRl and Tag-TCR2 mice as compared with littermate 
controls. Mesenteric lymph nodes were often found to be 
2-to 3-fold enlarged in older Tag-TCR2 mice as compared 
with normal C3H mice, and splenomegaly arose fre- 
Figure 2. Flow Cytometric Analysis of TCR (Id- 
iotype) and CD4KDS Expression in Tag-TCRl 
and Tag-TCR2 Transgenic Mice 
(Top) Threecolor analysis of CD4/CDS and Id 
expression on thymocytes and lymph node 
cells derived from a nontransgenic (neg.) lit- 
termate, a Tag-TM1 mouse, and a Tag- 
TM2 mouse. Cells were stained with anti- 
CDS-FITC, antiCD4-PE, and anti-Id-Tricolor. 
(Bottom) Twocolor analysis of idiotype (Id) and 
CD3 expression on thymocytes and lymph 
node cells of the same mice. Cells were stained 
with anti-CD%FITC and anti-Id-PE. Numbers 
indicate the percentage of cells in the respec- 
tive fluorescence window. 
quently. In contrast, TCRl mice had normal lymph nodes 
and spleens. 
With regard to the expression of the CD4 and CD8 core- 
ceptor molecules on the surface of T cells, a significant 
skewing towards the development of CD4+ T cells can be 
observed in lymph nodes of Tag-TCR2 mice, where the 
CD4/CD8 ratio is 4- to 5fold higher than that of negative 
littermates (Figure 2). Such preferential selection of CD4 
or CD8 single-positive T cells has been described pre- 
viously in other TCR transgenic mice (Sha et al., 1988a; 
Berg et al., 1989b; Kaye et al., 1989; Scott et al., 1989). 
In contrast with peripheral T cells, Tag-TCR2 thymocytes 
show no such skewing towards the, development of 
CD4+CD8- cells, the transgenic T cells rather appear to 
accumulate at a CD4CDB stage (Figure 2). We also ob- 
sewed a population of Id+CD8+ T cells in both the thymus 
and the periphery of Tag-TCR2 mice. These cells may 
have undergone rearrangement of an endogenous TCR 
a locus and thus express two functional TCR a chains 
on the surface. Alternatively, CD8+ T cells expressing the 
transgenic TCR may occasionally be positively selected 
in the thymus, a possibility suggested by a previous study 
(Kirberg et al., 1994). As predicted by the low frequency 
of Tag-specific(ld+)TcellsinTag-TCRl mice, noapparent 
change in the CD4/CD8 ratio of total peripheral T cells 
can be detected in these mice as compared with littermate 
controls. However, the population of Id+ T cells itself is 
strongly skewed towards the development of CD4+ cells 
(Figure 2). 
Reactivity of Id+ T Cells to Tag 
To test whether the transgenic T cells in Tag-TCRl and 
Tag-TCR2 mice were indeed specific for Tag, we isolated 
spleen and lymph node cells from the transgenic animals 
and stimulated them in vitro with various amounts of puri- 
fied Tag protein. Even in the absence of in vivo priming, 
the transgenic T cells proliferated vigorously to Tag, with 
a maximal response at l-2 days of culture for Tag-TCR2, 
and 2-3 days for Tag-TCRl (see Figures 3A and 38, bro- 
Immunity 
576 
Tag pglml o Tag pg/ml o 
Figure 3. Functional Analysis of Tolerance Induction in rag-TM/ 
FtT2] Double-Transgenic Mice 
(A) In vitro proliferation assay of lymph node cells derived from g-week- 
old nonimmunized Tag-TCR2 mice (broken lines, open circles), rag- 
TCR2/RT2] mice (solid lines, closed circles), or nontransgenic (nega- 
tive) littermates (dotted lines, closed triangles). Cells (5 x 10’) were 
incubated in duplicates with various concentrations of Tag for 42 hr, 
and labeled with pH]thymidinefor a final 6 hr. Shown are mean values 
obtained from two individual mice in each group. 
(6) The same proliferation assay described in (A) was performed with 
lymph node cells derived from &week-old Tag-TM1 (broken lines, 
open squares), rag-TCRlIRTP] mice (solid lines, closed squares) or 
negative littermates(dotted lines, closed triangles). Cells were cultured 
for 60 hr. 
(C) The concentration of Tag-specific IgG antibodies in the serum of 
nonimmunized RT2 (n = 7) (Tag-TCRIIRTP] (n = 6),and rag-TCR2/ 
RT2] (n = 6) mice was determined by ELISA. The horizontal line indi- 
cates the detection limit at 0.1 &ml. Mice were between 6 and 12 
weeks of age. 
ken lines; data not shown). The different kinetics of the 
response can be attributed to the higher frequency of Tag- 
specific T cells in Tag-TCR2 as compared with Tag-TCRl 
mice. 
Functional Analysis of T Cell Tolerance 
in Double-Transgenic Mice 
Next, we crossed the Tag-TCR transgenic mice to RIP- 
Tag transgenic mice that begin expressing Tag in their 
pancreatic 8 cells during embryogenesis to follow the fate 
of Tag-specific T cells in an environment in which tolerance 
induction normally takes place. For this purpose, we used 
the RT2 mice (Hanahan, 1985, Alpert et al., 1988). These 
mice normally establish systemic tolerance to Tag (Adams 
et al., 1987; Jolicoeur et al., 1994). As a functional readout 
for tolerance induction, we first examined the ability of 
the T cells from double-transgenic mice to proliferate in 
response to Tag in vitro. Mesenteric lymph node cells were 
isolated from nonimmunized mice, cultured in the pres- 
ence of various concentrations of Tag for 2-3 days, and 
pulsed with PH]thymidine to measure the Tag-dependent 
proliferation. Figure 3A shows the result of a representa- 
tive experiment in which the proliferative response of 
lymph node cells from [Tag-TCR2/RT2] double-trans- 
genie mice is compared with that of their Tag-TCR2single- 
transgenic and negative littermates. Surprisingly, the 
transgenic T cells from [Tag-TCR2/RT2] mice were fully 
responsive to Tag, showing no signs of tolerance induc- 
tion. Incontrast, lymph nodecelisof rag-TCRl/RT2]dou- 
ble-transgenic mice appeared nonresponsive in the same 
assay, when compared with ceils from Tag-TCRl single- 
transgenic animals (Figure 36). In sum, we analyzed 5 
[Tag-TCR2/RT2] and 10 [Tag-TCRl/RT2] double-trans- 
genie animals, together with an equivalent number of lit- 
termate control mice, obtaining a consistent result: no in 
vitro tolerance was established when the high frequency 
Tag-TCR2 line was cross-bred to RT2. In contrast, an 
almost complete absence of Tagdependent proliferation 
in lymph node cultures was observed when the lower fre- 
quency Tag-TCRl line was crossed to RT2. Of the 10 
animals analyzed in the latter group, about half developed 
a weak residual response at high concentrations of Tag 
( >2 @ml) (see also Figure 5). 
Based on the finding that peripheral T cells of [Tag- 
TCR2/RT2] double-transgenic animals were not tolerant 
to Tag in vitro, we next asked whether the mice would 
produce spontaneous autoantibodies to Tag in vivo. The 
titers of Tag-specific immunoglobulin G (IgG) in sera of 
nonimmunized double-transgenic mice and single-trans- 
genie controls were determined by enzyme-linked immu- 
nosorbent assay (ELISA). As shown in Figure 3C, 7 of 8 
(Tag-TCR2/RT2] mice had significant titers of Tag- 
specific IgG antibodies in their serum, although the abso- 
lute levels were 19 to 59fold lower than those normally 
found in spontaneouslyautoimmune RIP1 -Tag5 mice with 
delayed onset of Tag expression. In contrast, no Tag- 
specific autoantibodies could be detected in the serum of 
[Tag-TCRl/RT2] double-transgenic mice, which were, by 
this assay, indistinguishable from the tolerant RT2 mice. 
We also never detected Tagspecific antibodies in the se- 
rum of Tag-TCRl or Tag-TCR2 single-transgenic mice 
(data not shown). 
Partial Deletion and Functional Impairment of 
Transgenic T Ceils in Fag-TCRl/RT2] 
Double-Transgenic Mice 
Next, we asked how the transgenic T cells were tolerized 
in [Tag-TCRl /RT2] double-transgenic animals. Were they 
physically deleted from the lymphocyte population or func- 
tionally inactivated? The frequency of Id+ T cells in the 
thymus and peripheral lymphoid organs of [Tag-TCR11 
RT2] mice, Tag-TCRl single-transgenic mice, and nega- 
tive littermates, was examined by flow cytometry. Since 
the frequency of Id+ T cells is generally low in the thymus 
of Tag-TCRl mice (<lo!), we specifically gated on the 
more mature CD3”’ thymocytes in the FACS analysis 
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Figure 4. Representation of Anti-Tag (Id’) Cells during Thymic Devel- 
opment and in Peripheral Lymph Nodes of a (Tag-TCRiIRT2] Mouse, 
a Tag-TCRl Single-Transgenic Mouse, and a Negative Littermate 
(A) Flow cytometric analysis of thymocytes gated for CD3N expression. 
Cells were stained with anti-CDS-FITC and anti-Id-PE. 
(B) Three-color analysis of thymocytes stained with antiCDB-FITC, 
antKD4-PE, and anti-Id-Tricolor). Cells (7,000) were collected from 
each sample by setting a life gate, which enriched for Id+ cells. The 
CD4KDS expression pattern of cells in the Id+ gate only is shown in 
the figure. A total of 175, 370. and 480 cells were present in this gate 
for the negative littermate, the Tag-TCRI, or the rag-TCRIIRTP] 
mouse, respectively. 
(C) Lymph node cells were stained with anti-CDS-FITC and anti-ld- 
PE. Numbers indicate the percentage of cells in each fluorescence 
window. 
shown in Figure 4A to visualize better the Tag-specific 
(Id+) cells in the thymus. Among these cells, the frequency 
of Id+ T cells was found to be on the order of 4%-5% 
(see also Figure 2). No difference was seen either in the 
frequency of Tag-specific T cells or in the level of Tag- 
specific TCR expression on thymocytes of Tag-TCRl sin- 
gle-transgenic and [Tag-TCRlIRT2) double-transgenic 
mice (Figure 4A). On average, 0.54% f 0.16% of total 
thymocytes were Id+ in Tag-TCRl mice (n = 7) compared 
with 0.46% f 0.16% in Tag-TCRlIRT2 mice (n = 6). 
We also examined CD4/CD6 expression on gated Id+ thy- 
mocytes of both types of mice and observed no difference, 
ruling out the possibility that the Id+ T cells in the thymus 
of [Tag-TCRlIRT2J mice were actually a population of 
negatively selected CD4CD6- thymocytes (Figure 48). 
Thus, no apparent thymic deletion of the Tag-specific (Id+) 
T cells could be detected in [Tag-TCRl/RT2] double- 
transgenic mice. 
In contrast with the analysis of thymocytes, a significant 
reduction of Id+ T cells was obsewed in the lymph nodes, 
spleen, and peripheral blood of [Tag-TCRl/RT2] double- 
transgenic mice. In Figure 4C, representative stainings of 
lymph node cells derived from a negative littermate, a 
Tag-TCRl mouse, and a [Tag-TCRlIRT2J mouse are 
depicted. In general, the frequency of Id+ cells was re- 
duced by about 60% in [Tag-TCRl/RT2] compared with 
Tag-TCRl single-transgenic mice, with a mean value of 
7.6% f 1.0% of Id+ T cells in Tag-TCRl mice, and 
0.9% f 0.3% in jTag-TCRl/RT2] mice. To determine 
whether the disappearance of the Id+ T cells in jTag- 
TCRllRTP] mice was due to down-regulation of the TCR, 
as Hammerling et al. (1993) have described, we stained 
the cells with antLThy1, anti-CDS, and anti-Id antibodies 
to look for the appearance of a Thyl+CD3Id- population 
of cells in [Tag-TCRlIRT2J mice. No such population 
could be detected, indicating that the disappearance of 
the Tag-specific (Id+) T cells in these mice was due to 
physical deletion rather than down-regulation of the TCR 
(data not shown). In addition, we also examined expres- 
sion of the CD4 coreceptor molecule on the Tag-specific 
(Id+) T cells. The number of Id+ CD4- T cells was similar in 
Tag-TCRl only and [Tag-TCRl/RT2] double-transgenic 
mice; the remaining Id+ CD4+ T cells in the periphery of 
[Tag-TCRlIRT2J mice were found to express normal lev- 
elsof CD4. Thus, no obviousdown-regulation of CD4could 
be observed on the Tag-specific T cells of [Tag-TCRlI 
RT2] mice. 
An analogous set of experiments was then performed 
with thymocytes and peripheral lymphocyte populations 
obtained from crosses of the Tag-TCR2 line, which shows 
an approximately Qfold higher frequency of Tag-specific 
(Id+) T cells than Tag-TCRl. No apparent difference in 
thymic development of the Tag-specific T cells could be 
observed in [Tag-TCR2/RT2] double-transgenic as com- 
pared with Tag-TCR2 single-transgenic mice. In agree- 
ment with the lack of self-tolerance of Tag in [Tag-TCR2/ 
RT2] mice (see above), the number of Id+ T cells in the 
lymph nodes of these mice was not significantly reduced 
compared with Tag-TCR2 mice. Thus, [Tag-TCR2/RT2] 
double-transgenic mice contained 49.7% f 10.6% Id+ T 
cells among all lymph node cells (n = 5) compared with 
54.7% f 6.2% in Tag-TCR2 single-transgenic mice 
(n = 5). However, a slight reduction in the frequency of 
CD4+ IdmM cells could be detected in [Tag-TCR2/RT2] 
mice (31.6% f 7.4% compared with 45.1% f 7.6% in 
Tag-TCR2 mice). This effect was paralleled by a relative 
increase in CD6+ Id+ cells as well as CD4+ Id” cells, which 
may express endogenous TCR a chain rearrangements. 
The deletion of Tag-specific (Id+) T cells in the periphery 
of [Tag-TCRlIRT2] mice could explain the lack of Tag- 
specific in vitro proliferation of the lymph node cells de- 
rived from these mice. However, Tag-specific T cells were 
not completely absent from these cell populations; rather 
they accounted for 05%-l 5% of total lymph node cells. 
Were these remaining cells fully responsive to Tag, or 
were they in some way functionally impaired? To address 
this question, it was necessary to determine whether our 
in vitro proliferation assay was sensitive enough to pick 
up antigen-specific proliferation of such a minor subset of 
cells. We therefore adjusted the fractional representation 
of Id’T cells in the population of lymph node cells isolated 
from Tag-TCRl single-transgenic mice to match that 
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found in rag-TCRl/RT2] double-transgenic mice (ap- 
proximately 1%) by lo-fold dilution with lymph node cells 
from negative littermates. We then performed Tag prolifer- 
ation assays using these two cell populations, along with 
controls consisting of undiluted Tag-TM1 and non- 
transgenic lymph node cells. The frequency of Id+ cells in 
each cell population was determined by FACS, and found 
to be 1.1041, 1.4%, and 1.4% for the three [Tag-TCRl/ 
RT2J double-transgenic mice, and 0.9%, 0.6%, and 1.2% 
for the Tag-TCRl cells diluted with lymph node cells from 
negative littermates. The mean values of the proliferative 
responses toward Tag obtained for each of the four differ- 
ent groups are depicted in Figure 5. It is apparent from 
this experiment that a much stronger proliferation takes 
place in the cultures in which Tag-TCRl cells were diluted 
with nontransgenic cells than in cultures of lymph node 
cells from [Tag-TCRi/RT2] double-transgenic animals, 
1033 
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Figure 5. Analysis of the Tag-Specific Proliferative Response of 
Lymph Node Cells from rag-TCRl/RT2] Double-Transgenic and 
Tag-TCRI Single-Transgenic Mice after Adjustment for the Relative 
Frequency of Id+ T Cells 
The following groups were analyzed: nontransgenic (negative) lit- 
termates (dotted lines, open squares), Tag-TCRI (broken lines, closed 
squares), Tag-TCRl diluted I:10 with lymph node cells from sex- 
matched negative littermates (solid lines, open triangles), and [Tag- 
TCRl/RT2] double-transgenic mice (broken lines, closed circles). 
Three individual mice were analyzed in each group and mean values 
f SD are plotted for each group. The fraction of Id+ cells in each cell 
population was the following: 0.05, 0.02, 0.07 (negative littermates); 
7.3, 5.08, 10.06 (Tag-TCRl); 0.88, 0.55, 1.19 (Tag-TCRllnegative 
littermate. 1:lO); and 1 .OS. 1.43, 1.42 (rag-TCRlIRT2j). Cells were 
cultured for 72 hr and labeled with ~H~hymidine for the IasIS hr. The 
somewhat higher background proliferation for the mixed cell popula- 
tions (Tag-TCRllnegative littermate, 1:lO) is due to an increased 
background in one of the three independent cultures that may have 
been caused by a minor alloreactivity between the Tag-TCRl and the 
negative littermate lymph node cells. 
even though the frequency of Id+ cells in the former cell 
populations was slightly higher than in the latter ones. We 
conclude from this experiment that the remaining Tag- 
specific (Id+) cells in [Tag-TCRl/RT2] double-transgenic 
mice are, to some extent, functionally nonresponsive, al- 
though a small residual response can be detected in some 
of the mice at high concentrations of antigen. The de- 
creased responsiveness of these cells is not due to down- 
regulation of their TCR or CD4 as determined by FACS 
analysis (see above). Taken together, the tolerance of 
[Tag-TCRl/RT2] double-transgenic mice towards Tag 
was found to result from deletion of >60% of Tag-specific 
(Id+) T cells, and induction of nonresponsiveness (or an- 
ergy) in the remaining Tag-specific T cells, 
Lymphocytic Infiltration of the Pancreatic Islets 
in Double-Tranegenlc Mice 
In contrast with the RIPl-Tag5 transgenic lineage, which 
evidences delayed onset of Tag expression and conse- 
quent 6 cell autoimmunity, the tolerant RT2 mice do not 
normally develop lymphocytic infiltration of their pancre- 
atic islets. Since the (Tag-TCR2/RT2] double-transgenic 
mice were found to be nontolerant in the experiments de- 
scribed above, we examined the pancreases of these and 
[Tag-TCRl/RT2] mice for the development of insulitis. As 
predicted from the lack of T cell tolerance in rag-TCR2/ 
RT2) mice with a high frequency of transgenic T cells, a 
dramatic infiltration of the islets was observed in these 
mice. Thus, of a total of 60 islets examined in the pancreas 
of four different 9- to lo-week-old [Tag-TCR2/RT2] ani- 
mals, 47 (76%) were infiltrated, manifested as a massive 
intraislet infiltration that was composed predominantly of 
CD4+ T cells and B cells, and a smaller fraction of CD6+ 
T cells (Figures 6a-6e). We presume that the CD4+ T cells 
in these infiltrates are mostly transgenic T cells, since no 
such infiltration can be detected in either the RT2 or the 
Tag-TCR2 single-transgenic animals. (This prediction has 
not yet been directly confirmed due to a technical inability 
to use the anti-idiotypic antibody for immunohistology.) 
The 6 cells occupying the core of the islets in RT2 animals 
can be visualized with Tag-specific antibodies. Notably, 
the numbers of Tag-expressing 5 cells were clearly re- 
duced in the infiltrated islets of [Tag-TCR2/RT2] mice (Fig- 
ure Se), consistent with ongoing 9 cell destruction. Yet, 
despite the severe insulitis in these mice, pancreatic f3 cell 
tumors still develop as a consequence of the oncogenic 
activity of Tag (Hanahan, 1965). The appearance of these 
insulinomas beginning at about 10 weeks of age likely 
explains the fact that [Tag-TCR2/RT2] mice do not de- 
velop diabetes. The failure of the anti-Tag immune re- 
sponse to prevent tumor formation may result from insuffi- 
cient numbers of CD6’T cells, or from selective inhibition 
of high endothelial venules in the tumors, as is observed 
in the tumors of autoimmune RIPl-Tag5 mice (S. Onrust, 
P. Hartl, S. Rosen, and D. H., unpublished data). 
Surprisingly, [Tag-TCRl/RT2] double-transgenic mice, 
which evidence deletion of about 60% of Tag-specific (Id+) 
T cells, nevertheless showed mild lymphocytic infiltration 
of the pancreatic islets, even though the remaining Id+ T 
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Tag-TCR2/RT2 Tag-TCRl/RT2 Figure 6. Comparison of Lymphocytic At- 
traction to the Pancreatic Islets of nag-TCFW 
RT2] and [Tag-TCR 2/RT2] Mice 
Adjacent frozen sections derived from the pan- 
creas of a 9-weekold jTag-TCR2/RT2] (a-e) 
and an &week-old rag-TCRi/RT2] mouse 
(f-j) were stained with hematoxylin-eosin (H & 
E); antiCD4, antiCD6, or anti-B220 (Vector- 
Red); and anti-Tag 33 diaminobanzidine as 
indicated in the figure. Magnification, 192 x 
Areas of remaining islet cell tissue are indi- 
cated by arrows in jTag-TCR2/RT2j sections 
a and e. For better visualization of nuclear Tag 
expression in the 6 cells, selected regions of 
the sections (see inserts) are shown at higher 
magnification in the upper right corners of e 
and j. For further explanation see text. 
cells were largely unresponsive to Tag in vitro. However, 
insulitis was infrequent in [Tag-TCRlIRT21 mice, in con- 
trast with [Tag-TCR2/RT2) mice. In one analysis, only 
12% of the islets showed infiltration; 14 of 115 islets were 
infiltrated in tissue sections obtained from five different 
8- to lo-week-old [Tag-TCRlIRT21 mice. The infiltration 
seen in these cases was almost exclusively pen-islet, i. e., 
the lymphocytes accumulated at one side of the islet but 
did not invade it (Figures Sf-8j). As in [Tag-TCR2/RT2] 
mice, the infiltrates were mostly composed of CD4+ T cells 
and 6 cells, but included a minor population of CD8+ T 
cells. It is striking that despite the presence of both CD4+ 
T cells and B cells in these infiltrates, Tag-specific autoan- 
tibodies were not detected in [Tag-TCRl/RT2] mice (see 
Figure 3C), again likely belying the functional impairment 
of the Tag-specific (Id+) T cells. In summary, lymphocytic 
infiltration could be detected in both [Tag-TCRl/RT2] and 
jTag-TCR2/RT2] double-transgenic mice, but the pattern 
was qualitatively and quantitatively different in the two 
types of mice. While the vast majority of islets had severe 
infiltration in [Tag-TCR2/RT2] animals, only 12% of the 
islets were affected in [Tag-TCRl /RT2] mice, wtth a mostly 
pen-islet accumulation of lymphocytes. 
Transgenlc T Cells from Tag-TM2 Mice Can Be 
Tolerlzed If Present at a Lower Frequency 
To assess whether the inability to tolerize Tag-sbecific T 
cells from the Tag-TCR2 line is a result of their high fre- 
quency rather than a bias conferred by the transgene inte- 
gration site, we generated mixed bone marrow (EM) chi- 
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meras in which BM derived from Tag-TCRZ’mice was 
diluted with various amounts of nontransgenic BM. For 
this purpose, RT2 mice or nontransgenic littermates were 
sublethally irradiated and reconstituted with BM cells de- 
rived from Tag-TCR2 mice only; Tag-TCR2 BM mixed 
with nontransgenic C3H BM; or Tag-TCRl BM as a con- 
trol. Reconstitution with Tag-TCR2 BM alone did not pro- 
duce the same high (80%-90%) frequency of transgenic 
T cells as found in unmanipulated Tag-TCR2 mice, but 
rather resulted in only 25%-30% of CD4+ T cells bearing 
the transgenic TCR. This lower frequency is most likely 
due to competition between the recipient-derived non- 
transgenic cells and the transgenic cells, since the recipi- 
ents were only sublethally irradiated. A similar phenome- 
non has been observed previously in a B cell receptor 
transgenic mouse model (Cyster et al., 1994). We deter- 
mined the frequency and proliferative response of Id+CD4+ 
Tcells in mesenteric lymph nodes derived from BM chime- 
ras that were either on a RT2 or on a nontransgenic back- 
ground. A summary of the data obtained from transfers 
of Tag-TCR2 BM, TCR2/C3H BM at ratios of 20:1, 5:1, 
and l:l, C3H BM, and of Tag-TCRl BM is presented in 
Figure 7. In every experiment, except for the C3H BM 
transfer, the Tag-specific proliferation was clearly reduced 
in lymph node cells resident in RT2 recipients (solid lines), 
as compared with those in nontransgenic recipients (bro- 
ken lines). This reduced responsiveness was least pro- 
nounced following transfer of Tag-TCR2 BM alone, and 
progressively stronger at TCR2/C3H ratios of 20:1, 5:1, 
and l:l, although in the latter case the Id+ T cells were 
barely detectable and only gave a relatively low prolifera- 
tive response in the nontransgenic recipients. The dimin- 
ished proliferative responses in RT2 recipients can partly 
be explained by the reduced frequency of Id+CD4+ periph- 
eral T cells as compared with the frequencies found in 
nontransgenic recipients (Figure 78). In addition, the data 
suggest partial anergy of the remaining Id+ cells (see also 
Figure 5). Among the various mixtures of transgenic and 
nontransgenic BM, we found that a 5-fold excess of Tag- 
TCRP BM over nontransgenic BM resulted in a frequency 
of transgenic T cells that was comparable to that found 
in chimeras reconstituted with Tag-TCRl BM, and slightly 
lower than that found in normal Tag-TCRl mice (see Fig- 
ure 78). When chimeras from the 5:l transfer are com- 
pared with those carrying Tag-TCRl BM, it is clear that 
both show similar reductions in the number and the re- 
sponsiveness of Id+CD4+ cells when these cells develop 
in a RT2 background, as compared with a nontransgenic 
background. Therefore, we conclude that the Tag-specific 
T cells from Tag-TCR2 mice are as readily tolerized as 
those derived from Tag-TCRl mice if they are present at 
a similarly low frequency (less than lo%-15% of total T 
cells). 
Discussion 
In the present study, we describe a transgenic mouse 
model in which tolerance towards a rare self-antigen can 
be induced in CD4+ transgenic T cells. The TCR variable 
genes have been cloned out of an autoreactive CD4+ T 
Origin of Oonor Bone Marrow Tag-TCR Transgenic Mice 
Figure 7. Tag-Specific Proliferative Response and Representation of 
Transgenic T Cells in Lymph Nodes of Mixed BM Chimeras 
(A) In vitro proliferation assay of mesenteric lymph node cells derived 
from BM chimeras 4-6 weeks after BM reconstitution. Mice were ra 
constituted with Tag-TM2 BM, TCWC3H BM at ratios of 20:1, 5: 
I, and l:l, C3H BM, or Tag-TCRI BM as indicated in the figure. A 
total of six individual mice, three RT2 recipients (solid lines), and three 
negative (nontransgenic) littermates (broken lines) were analyzed in 
each group. Cells (4 x 109 were incubated in triplicates with various 
concentrations of Tag for 72 hr and labeled with [3H]thymidine for the 
last 6-6 hr. Shown are mean values of triplicates f SD for each 
individual mouse. Cpm values were determined using the Matrix 9600 
counter (see Experimental Procedures). 
(6) Percentage of ld+CD4+ cells as a fraction of total lymph node cells 
in the cell suspensions used for the proliferation assays shown in (A), 
as determined by FACS analysis. Shown are mean values f SD for 
the three nontransgenic (closed bars) and the three RT2 recipients 
(hatched bars) in each group. In the right of (B), the frequencies of 
Id+CDQ T cells in lymph nodes of unmanilulated Tag-TCR2 and Tag- 
TCRI transgenic mice are shown for comparison, both in single- 
transgenic and in RT2 double-transgenic backgrounds. (The propor- 
tion of total T cells in the lymph node cell suspensions was generally 
between 50% and 70%) The frequencies of Id+ cells in the thymi of 
these same BM chimeras were the following: Tag-TCR2 BM alone, 
52.0% f 23.0%; TCR2/C3H (20:1), 25.7% 2 14.2%; TCR2/C3H 
(51) 4.2% f 1.4%; TCR21C3H (1 :I). 0.6% 2 0.6%; and Tag-TCRl 
BM alone, 1.2% f 0.3%. There was no significant difference in the 
frequency of Id+ thymocytes between nontransgenic and transgenic 
recipients. 
cell that was infiltrating a pancreatic islet as part of an 
autoimmune response against SV40 Tag. Rearranged 
TCR genes were constructed, and used to derive two lines 
of transgenic mice, Tag-TCRl and Tag-TCR2, that ex- 
press this Tag-specific TCR on 10% and 90% of peripheral 
T cells, respectively, as revealed by FACS analysis with 
an anti-idiotypic antibody recognizing this receptor. Reca- 
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pitulating the bias toward CD4+ T cells of the parental line, 
a majority of T cells carrying this receptor express CD4. 
Peripheral lymphocytes are demonstrably reactive to- 
wards Tag, much as the parental clone. 
When these Tag-TCR lines are crossed to the RT2 line, 
which establishes systemic tolerance toward Tag, the Tag- 
specific T cells show alternative fates. In [Tag-TCRlI 
RT2], only 20% of the normal fraction of Tag-specific (Id+) 
T ceils are present in the peripheral immune system of 
the double-transgenic mice, as compared with mice car- 
rying the Tag-TCRl transgene alone, despite normal 
numbers in the thymus. Those Id+ T cells that populate 
the periphery show reduced responsiveness toward Tag. 
In contrast, in [Tag-TCR2/RT2] mice, normal numbersof 
Tag-specificT cells populate the periphery, and these cells 
are fully responsive towards Tag. Moreover, the Tag- 
specific T cells heavily infiltrate the islets, which express 
Tag in their 8 cells. While in the [Tag-TCRl/RT2] cross T 
ceils are also attracted to the islets, they collect in peri-islet 
clusters and do not significantly infiltrate into the islets. 
Thus, comparison of these two Tag-TCR lines has re- 
vealed significant phenotypic differences in response to 
the same self-antigen. Using mixed BM chimeras, we fur- 
ther show that the differences between the two lines, of 
deletion and tolerance versus normal development and 
full responsiveness, can be ascribed to the proportion of 
T lymphocytes that develop expressing this rearranged 
Tag-specific TCR. When less than lo%-15% of T cells 
are Tag specific, tolerance is induced, whereas increasing 
the number to a majority results in a failure to induce toler- 
ance in a background RT2, which normally establishes 
systemic self-tolerance of Tag. 
Several previous studies have sought to examine the 
mechanism of tolerance induction of CD4+ T cells. With 
the exception of experiments on major histocompatibility 
complex (MHC) alloreactive cells and of a TCR transgenic 
mouse model specific for the complement component C5 
(Zal et al., 1994) most studies performed in TCR trans- 
genie mice found that tolerization of CD4+ autoreactive T 
cells did not occur (Goverman et al., 1993; Katz et al., 
1993; Scott et al., 1994; Lafaille et al., 1 SS4), or could only 
be achieved following treatment of the animals with high 
doses of exogenous antigen or peptide (Murphy et al., 
1990; Critchfield et al., 1994, Kearney et al., 1994). Our 
finding, that the abundance of self-reactive T cells affects 
the success or failure of tolerance induction, may offer an 
explanation for the lack of tolerance by CD4+ T cells in 
other TCR transgenic mouse models. 
The Mechanism of Tolerance Induction 
in [Tag-TCRl/RT2] Mice 
Three lines of evidence from comparisons with Tag-TCRl 
single-transgenic mice suggest that [Tag-TCRl/RT2] 
double-transgenic mice are tolerant of Tag: first, the ab- 
sence of about 80% of Id+ T cells normally seen in the 
peripheral immune system (Figure 4); second, impaired 
responsiveness of the remaining transgenic Tcells (Figure 
5); and third, the lack of Tag-specific autoantibody produc- 
tion (Figure 3C). Yet, the pancreatic inflamation observed 
in [Tag-TCRl/RT2] mice could be taken to suggest that 
in vivo tolerance towards Tag is incomplete in these mice. 
However, it is intriguing that these lymphocytic infiltrates 
are found almost exclusively in pen-islet clusters, much as 
is seen in crosses of NOD mice with the diabetes-resistant 
strain NON, in which Fl mice evidence lymphocyte at- 
traction to the islets, but not the massive infiltration and 
islet cell destruction evident in the NOD-associated auto- 
immune response (Prochazka et al., 1987). Moreover, de- 
spite the presence of large numbers of B cells in these 
pen-islet clusters, no Tag-specific antibodies were de- 
tected in serum, consistent with systemic tolerance. Asim- 
ilar observation, of transgenic T cell nonresponsiveness 
accompanied by lymphocytic infiltration in the pancreas, 
has been reported previously for a MHC class l-restricted 
model, whereby Ld-specific TCR transgenic mice were 
crossed to Elastase-Ld transgenic mice that express the 
Ld molecule in the exocrine pancreas (Fields and Loh, 
1992). 
We have recently reported that low level of transcription 
of the RlPl-Tag transgene can be detected in the thymus 
of neonatal RT2 mice (Jolicoeur et al., 1994) in line with 
observations by others using RIP (Heath et al., 1992, von 
Herrath et al., 1994). Remarkably, this thymic expression 
reflects a property of the endogenous insulin genes, as 
well as other pancreatic genes, which also evidence low 
level transcripts in the thymus (Jolicoeur et al., 1994). 
Thus, the thymus may very well play a role in the induction 
of tolerance towards antigens that are otherwise ex- 
pressed only in peripheral organs. We did not detect signif- 
icant deletion of the Tag-specific (Id+) T cells in the thymus 
of [Tag-TCRl/RT2] animals (see text; Figure 4). This re- 
sult does not exclude the possibility that the transgenic 
T cells present in the thymus of [Tag-TCRl/RT2] mice 
receive some tolerizing signal there and subsequently die 
in the periphery either without any further stimulus, or upon 
a second encounter with the autoantigen, as hypothesized 
by Hammerling et al. (1993). An alternative possibility is 
that Tag-specific CD4+ T cells are deleted in the thymus 
of normal RT2 mice but not in [Tag-TCRlIRT2J double- 
transgenic mice, owing to the dramatically increased num- 
ber of Tag-specific T cells. Thus, in this circumstance, 
tolerance might be established by a supplementary (post- 
thymic) mechanism in the periphery. These possibilities 
should be distinguishable in future experiments wherein 
mature Tag-specific thymocytes as well as Tag-specific 
(Id+) T cells isolated from the pancreas and lymph nodes 
of [Tag-TCRl /RT2] mice will be analyzed by in vitro prolif- 
eration assays. 
Is the Tolerizing Capability of Rare 
Self-Antigens Limited? 
Our results are consistent with an earlier study (Scott et 
al., 1994) in implying that the tolerance induction machin- 
ery can tolerize only a limited number of autoreactive T 
cells when the self-antigen is expressed at very low levels 
or in a highly tissue-specific manner. Presuming that thy- 
mocytes require contact with self-antigen to become toler- 
ized, it is not surprising that the overwhelming number of 
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antigen-specific T cells in TCR transgenic mice may simply 
be overloading the tolerizing machinery, leading to the 
escape of autoreactive cells into the functional lymphocyte 
pool. From the BM transfer experiments presented in Fig- 
ure 7, one may conclude that the threshold below which 
the autoreactive T cells in our TCR transgenic mice are 
efficiently tolerized is around 100/b-15% of total T cells. 
In other systems this value may well be different, de- 
pending on the abundancy of the target antigen and the 
affinity of the respective TCR. Thus, CD4+ T cells specific 
for an abundant component of the complement system 
were efficiently deleted in the thymus even when these 
cells accounted for the entire T cell population in a RAG- 
deficient mouse (Zal et al., 1994). On the other hand, it 
is possible that autoreactive T cells specific for very rare 
or sequestered antigens may sometimes exceed the 
threshold of tolerance induction even in an unmanipulated 
(non-TCR transgenic) immune system, and potentially 
cause an autoimmune reaction following activation. 
Recently, several reports have described the depen- 
dence of thymic T cell selection on the density of MHC 
molecules loaded with antigenic peptide in the thymus (or 
thymic organ culture), leading to positive selection at low 
concentrations of antigen (low avidity interaction) and neg- 
ative selection at high concentrationsof antigen (high avid- 
ity interaction) (Ashton-Rickardt et al., 1994; Hogquist et 
al., 1994; Sebzda et al., 1994). In the rag-TCR/RT2] dou- 
ble-transgenic mice, the amount of Tag antigen is kept at 
a low but constant level by the use of the same RT2 line, 
while the frequency of antigen-specific T cells is varied by 
cross-breeding with the two Tag-TCR lines. Thus, these 
distinct experimental approaches both suggest that the 
balance between the amount of antigen, the number of 
antigen-presenting cells, and the number of self-reactive T 
cells eventually determines the outcome of T cell selection 
during development. Using TCR 5 chain transgenic mice, 
it has recently been reported that the level of TCR expres- 
sion on the surface of T cells can be critical for the induc- 
tion of T cell tolerance in vivo (Homer et al., 1993). Al- 
though we did not detect a significant difference in the 
amount of the transgenic TCR on the surface of T cells 
from Tag-TCRl as compared with Tag-TCR2 mice, it can- 
not be excluded that subtle differences in the onset and 
level of TCR expression differentially alter thymic develop- 
ment in Tag-TCRl versus Tag-TCR2 mice. However, 
based on the result of the BM transfer experiments de- 
scribed above, it seems unlikely that differences in the 
level of TCR expression account for the presence or ab- 
sence of tolerance induction in the rag-TCFURT2J 
crosses described in this study. 
Another component to the failure of tolerance induction 
towards peripheral antigens in TCR transgenic mice with 
high frequencies of transgenic T cells may be regulatory 
processes involving interactions between different sub- 
sets of T cells that collectively serve to produce the tolerant 
phenotype. Such cell-cell interactions could well be im- 
paired in a TCR transgenic mouse that is dominated by 
a single CD4+ T cell type. An experiment supporting this 
notion has recently been described by Lafaille et al. (1994) 
in which the incidence of autoimmune disease was dra- 
matically increased in myelin basic protein-specific TCR 
transgenic mice on a RAG-deficient background as com- 
pared with normal TCR transgenic mice, even though the 
absolute number of transgenic T cells was identical in the 
two types of mice. Experiments that restore T cell diversity 
by mixing T cells derived from the tolerant [Tag-TCRlI 
RT2] mice with those of the nontolerant [Tag-TCR2/RT2] 
double-transgenic mice may serve to clarify the role of 
regulatory cell-cell interactions in our system. 
In conclusion, we have generated a transgenic mouse 
model in which tolerization of CD4+ T cells can be moni- 
tored in vivo. With the benefit of a highly specific anti- 
idiotypic antibody towards this Tag-specific TCR, even 
small numbers of antigen-specific T cells can be traced 
in the intact organism, aclear advantage over the analysis 
of tolerance induction in normal mice. This capability will 
allow us to monitor the fates of Tag-specific autoreactive 
Tcells in eithertolerant RIP-Tag backgroundswith embry- 
onic onset of Tag expression or in autoimmune RIP-Tag 
mice with delayed onset of Tag expression, thereby in- 
creasing our knowledge of the cellular and molecular pro- 
cesses involved both in development of self-tolerance to 
a rare cell type and in organ-specific autoimmune disease. 
Expwlmental Procedums 
Mice 
CIHeBIFeJ, BSD2F1, C57BR. and AKR/J mice were obtained from 
Jackson Laboratories (Bar Harbor, Maine). RIPl-Tag5 micB weregen- 
erated by microinjection of the RIPl-Tag construct (Hanahan, 1985) 
into fertilized eggs of C3HeB/FeJ mice (J. Bkowronski and D. H., un- 
published data). RT2 mice were originally generated in the BSD2F2 
background (Hanahan, lQS5) and have subsequently been back- 
crossed to C3H for more than 15 generations. Mice were kept under 
specific pathogen-free conditions in the animal facility at the University 
of California, San Francisco or in a conventional animal facility at the 
Institute for Genetics, Cologne. Ail experiments were performed with 
& to 19week-old mice if not stated otherwise. 
lsolstion of T C&II Llnas and Hybrldomas 
Tag-specific T ceil lines were isolated from infiltrated pancreatic islets 
of a P&week-old RiPl-Tag5 mouse. individual islets were isolated by 
coiiagenase digestion of the pancreas(Radvanyi et al., 1993) and were 
cultured in serum-free iscove’s modified Duibecco’s medium (CG- 
medium, Vitromex. Vilshofen, Federal Republic of Gemany) in the 
presence of 10 U/ml recombinant human IL-2 (Amgen, Thousand 
Oaks, California) for 3 weeks. Outgrowing lymphocytes were ex- 
pandedfoilowing aprotocol previouslydescribed by Reichetal. (19SQ). 
In brief, the cells were cultured in the absence of IL-2 for 2 days before 
restimulation and were then triggered with antigen (see below) in the 
presence of irradiated C3H spleen cells (3MKl rads from a Q-137 
source, 2 x 19Yml) as antigen-presenting ceils. IL-2 was added back 
to the medium 2 days later and the cells expanded for 3-4 weeks 
followed by another round of restimulation. To select for either CD4+ 
or CDB+ T cells, the original cultures were split and stimulated with 
purified Tag protein (Jolicceur et al., 1994) at a concentration of 15 
kg/ml, or with the Tagexpressing 5 tumor cell line f3TC20 (8 x l(r/ 
ml; Radvanyi et al., 1993) respectively. A total of two CD4+ and six 
CDS+ cell lines were isolated from the same mouse and propagated 
in culture for more than 5 months. T cell hybridomas were generated 
from the CD4+ cell lines by fusion with the thymoma line BW5147a‘p- 
provided by P. Marrack (White et al., lQS9) and were cloned by limiting 
dilution. In addition, we also isolated several T cell clones by limiting 
dilution of the 2.5T cell line. The antigen specificity of the various cell 
lines was confirmed by Tag-dependent secretion of IFNy (determined 
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by ELISA; Mosmann and Fong, 1989) or IL-2/IL4 as determined by 
proliferation of the IL-2AL4-dependent cell line tfT2 (Cherwinski et 
al., 1987) in the presence of serial dilutions of the culture supernatant 
obtained from the Tag-stimulated T cell lines. Proliferation of HT2 cells 
was quantified using the MTT assay (Mosmann, 1983). 
Cloning of the TCR Genes and Generatlon of TCR 
Transgenk Mice 
The TCR genes expressed in cell line 2.5T were first identified by 
RNA-polymerase chain reaction (PCR) using a modification of the 
RACE protocol (Frohman et al., 1988). In brief, cDNA was synthesized 
from 2.5T RNA using primers specific for the constant region of the 
TCR a or 8 chain (TCRa, IF02 S-GCACATTGATTTGGGAGTC-3’; 
TCR8, IF01 Y-GCCATTCACCCACCAGCTC-3’). The cDNA was tailed 
with oligo(dG) and the second strand synthesized using an oligo(dC) 
adapter primer (5’-GAAGGATCCGTCGACATCGATAATACGACT- 
CACTATAGGGACCCCCCCCCCCCS’; Frohman et al., 1988). The 
TCR a and 8 gene rearrangements were speciffcally amplified by two 
rounds of PCR with nested primers (R. Y-GAAGGATCCGTCGA- 
CATCGS’, R, 5’~TCGACATCGATAATACGACTCAC-3’; TCRa, IF04 5’- 
GGAATCTAGAGCGGCCGCGTGAACAGGCAGAGGGTGCS’. IF17 
5’~ClTGGCGGCCGCAGACCGAGGATClllTAACTG-3: TCR8: IF03 
5’GGAATCTAGAGCGGCCGCCCAAGCACACGAGGGTAGC3’ and 
IF14 5”CTTGACTAGTATGGCTCAAACAAGGAGAC-3’) containing 
appropriate restriction sites. Conditions used for PCR were the follow- 
ing: 94OC for 1 min, 85OC for 1 min, and 72OC for 2 min for 30 cycles 
following “hot start” at 80°C. The PCR products were cloned into 
pBluescript KS(+) (Stratagene) and sequenced. Two independent pro- 
ductive rearrangements of both TCR a and 5 were identified, indicating 
that the 2.5T cell line was composed of two different T cell clones. To 
determine whether both T cell clones were specific for Tag and which 
a paired with which 8 chain in the two different TCRs, we further 
analyzed the TCR a and 8 gene expression as well as Tag specificity 
in several T cell clones and T cell hybridomas derived from the original 
2.5T cell line. Hybridoma 2.5T.3.43 expressing a Vf38.3.DB2.1 J82.4 
and Va2JaMTl-27 rearrangement was then chosen for genomic clon- 
ing of its TCR gene rearrangements. The genomic TCR a and 8 re- 
arrangements were cloned as a 10.4 kb Bamtfl or 13 kbSacl fragment 
from size-selected genomic libraries of the hybridoma 2.5T.3.43 in the 
phage vector I2001 (provided by K. Murphy), respectively. Phages 
containing the TCR a or 8 rearrangements were identified by hybrtdiza- 
tion to the respective cDNA clones obtained from the parent cell line 
2.5T. The phage inserts were subcloned into pBluescript KS(-). 
For generation of the TCR a and 8 constructs, the genomic V gene 
rearrangements were inserted into cosmid vectors containing the ap- 
propriate constant region genes (provided by D. Loh and K. Murphy; 
Sha et al., 1988b). TCRa construct: the 10.4 kb BamHl fragment con- 
taining 8 kb of 5’and 3.8 kb of 3’flanking sequence of the VaZlaMTl- 
27 rearrangement was subcloned into the BamHl site of the vector 
pTZ19R (Pharmacia) modified by insertion of a Xhol linker into the 
Smal site. The insert was excised by digestion with Sall-Xhol and 
ligated into the Sall site of the cosmid vector CaBS2. The product of 
the ligation reaction was packaged into 1 particles using Gigapack 
Plus packaging extracts (Stratagene) and amplified by transformation 
of DH5a bacteria. The final 43.9 kb a chain construct was purified from 
vector DNA bydoubledigestion with Sal1 and Notl. TCRj3 construct: the 
13 kb Sacl genomic clone was subcloned into pBluescript KS(-). A 
8.2 kb Xhol-Sacll fragment containing the V58.3DJ82.4 rearrangement 
with 5.1 kb of 5’and 0.4 kb of d’flanking sequence was dephosphory- 
lated at the Sacll site and ligated in a trimolecular ligation to a 25 kb 
Sacll-Xhol fragment containing the genomic C82 locus obtained from 
the cosmid C41/45 (provided by D. Loh; Sha et al., 1988b) and the 
cosmid vector PCK-X (provided by K. Murphy), which was cut with 
Xhol and dephosphorylated at both ends. The final 31.2 kb 8 chain 
construct was separated from vector DNA by digestion with Xhol. 
To assure that the constructs were properly transcribed and trans- 
lated into TCR chains, the a and 8 constructs (both of which contained 
a neomycin resistance gene) were cotransfected into the TCR- T cell 
hybridoma 58a-8- (Letourneur and Malissen, 1989). For this purpose, 
15 ug of each construct were mixed with 5 x loo 5&r-8- cells in RPM1 
1840 medium supplemented with 8% fetal caff serum and HEPES 
buffer. Transfection conditions were 309 V and 980 mF using a BioRad 
electroporator. Transfectante were selected in bulk culture for 2 weeks 
in 6418 containing medium (1.5 mg/ml) and subsequently analyzed 
for TCR expression using antibodies specific for Va2, V88.3, and idio- 
type-specific antibodies. All antibodies specifically stained2846 of the 
cells of the bulk cufture, confirming that both constructs could be ex- 
pressed in T cells (data not shown). 
For generation of transgenic mice, the two constructs were win- 
jetted into fertilized eggs of B8D2F2 mice. Three independent found- 
ers were obtained, two of which were a8 double-transgenic and one 
was a 8 chain only transgenic. The two a8 double-transgenic lines 
were designated as Tag-TCRI and Tag-TCR2. Tag-TCRI mice carry 
two copies of the TCR 8 chain transgene and one copy of TCR a, 
wintegrated into the same locus. The Tag-TCR2 line has multiple 
copies of both the TCR a and 8 chain wnstructs, again apparently 
wintegrated at one site. All of the B8D2F2 founders were backcrossed 
to C3H mice and screened for homozygosity of H-2k in the second 
backcross generation. Mice used for the experiments described below 
were backcrossed to C3H for 3-7 generations. 
Production of Anti-ldlotypk AntIbodIes 
For isolation of anti-idiotypic and V88.3-specific antibodies, C57BR 
and AKfUJ mice were immunized three times with 1.5 x 10’2.5T.3.43 
hybridoma cells intraperttoneally every 2 weeks. The mice. were 
boosted again 3 months after the last immunizatfon for one or two 
times in the same way and finally received an intravenous boost with 
1 x 10’ cells 3 days before the fusion. Spleen cells were fused to 
the myeloma line X83.Ag8.853 (Keamey et al., 1979) and hybrfdoma 
supernatants were screened 2 weeks later by a functional TCR cross- 
linking assay according to a protocol previously described by0. Kana- 
gawa (1988). Hybridomas that secreted antibodies that bound to the 
2.5T.3.43 TCR were cloned by limiting dilution and their fine specificity 
was determined by screening on a panel of different T cell hybridomas 
expressing either V88.1, V58.2, Vf38.3, or Va2 variable regions (data 
not shown). Out of a total of 11 TCR-specific hybridomas obtained 
from two independent fusions, 5 were specific for Vf38.3 and 8 were 
anti-idiotypic, i.e., not binding to any of the other Vf38.8 or Va2- 
expressing hybridomas tested. The anti-fdiotypic antibody 9H5 used 
in the present experiments was derived from an AKR/J mouse and is 
of the IgG2a isotype. 
Cytofluorometrk Analysis 
Fluorescence staining of cells was performed as dwcribed previously 
(FOrster and Rajewsky, 1987). Cells were analyzed on a FACScan 
(Becton Dickinson, Mountain View, California). Antibodies used for 
staining were GK1.5 (antfCM; Dialynas et al., 1983) coupled to phy- 
coerythrin (PE), 53-8.7 (antiCDB; Ledbetter, 1979) coupled to fluores- 
cein isothiocyanate (FITC), 145-2Cll-FITC (antiCD3; Leo et al., 
1987), HC-1314-PE (anti-Thyl.2; Marshak-Rothstein et al., 1979) 
B20.1-FITC (anti-VaP, Pharmingen), and biotinylated 9H5 antibody 
(see above) detected by either streptavfdin-PE for two-color analysis 
or streptavidin-Tricolor (Medac, Hamburg, Federal Republic of Ger- 
many) for three-color analysis. 
Prollferatlon Assay 
Mewnteric lymph node cells were isolated from nonimmunized TCR 
transgenic or tiiermate control mice. Cells were cultured in 95well 
flat-bottomed tissue culture plates (Costar) at 4 x l(P cells/well in 
RPM1 1840 medium (GIBCC) containing 10% fetal calf serum, 2-mer- 
captoethanol and penicillin/streptomycfn in the presence of various 
concentrations of Tag protein (Jolicoeur et al., 1994) as indicated. 
Cultureswere maintained for 48-72 hr and labeledwith 1 pCi PHjthymi- 
dine for the last 8 hr of the culture. The cells were then harvested on 
glass fiber filters and incorporated PHFhymidlne ww quantlffed by 
liquid scintillation counting (Figures 3 and 5) or using a Matrix 9880 
direct 8 counter (Canberra Packard, Frankfurt, Federal Republic of 
Germany) whose counting efficiency is 6 to Efold lower than that of 
a liquid scintllation counter, explaining the lower cpm vafuw presented 
in Figure 7. Cultures were performed either in duplicates or triplicates 
and mean values are shown in the figures. 
DetectIon of TagSpecIfIc Autoantlbodfes 
Tag-specific autoantibodies were detected in the wra of mice using a 
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standard ELISA protocol (FOrster and Rajewsky, 1967). In brief, plates 
were coated with 5 pg/ml Tag in phospate-buffered saline and blocked 
with 1% bovine serum albumin. Titrations of sera or the Tag-specific 
monoclonal antibody 419 (Harlow et al., 1961) as a standard were 
detected by a biotinylated goat anti-mouse IgG antiserum (SBA, Bir- 
mingham, Alabama) followed by streptavidin-alkaline phosphatase 
and pnitrophenylphosphate as substrate. 
BM Trenefer Experiments 
BM cells were isolated by flushing the femurs of donor mice wtth phos- 
phate-buffered saline. BM cell suspensions were depleted of mature 
T cells by incubation with anti-Thyl.2 antibodies coupled to magnetic 
beads followed by MlniMACS separation (Miltenyi Biotec, Bergisch 
Gladbach, Federal Republic of Germany). A total of 1 x 10’ T cell- 
depleted BM cells were injected intravenously into either FtT2 mice 
or negative littermates 1 day after irradiation with 600 rads from an 
X-ray source. Recipient mice were between 4 and 5 weeks of age and 
were analyzed 4-6 weeks after BM transfer. 
Histology 
Hematoxylin-eosin (H-E) staining of 10 pm frozen sections was per- 
formed according to standard procedures using hematoxytin Gill #3 
and eosin Y (Sigma). For immunostaining. sections were air dried, 
fixed in ice-cold acetone, blocked in Tris-buffered saline containing 
4% fetal calf serum, and stained with GKl.5 (antiCD4), 536.7 (anti- 
CDE), or RA3.682 (anti-B220; Coffman and Weissman, 1961). Primary 
antibodies were detected with biotinylated rabbit anti-rat IgG (Vector 
Laboratories, Burlingame, California) and avidin-alkaline phospha- 
tase using the ABC-AP and Vector red substrate kit (Vector). For Tag 
staining, sections were blocked with 4% goat serum and stained with 
a rabbit anti-Tag antiserum followed by peroxidase-labeled goat anti- 
rabbit IgG (Vector) and 3,3’diaminobenzidine substrate (Vector). 
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